reference/36278689

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36278689

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1993
issn	1476-5551 0887-6924
issueIdentifier	10
pageRange	1982-1993
publicationName	Leukemia
startingPage	1982
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3cddb49e35f93159f814fd9710969cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a45d026d648b958900af1c7693a9a05 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_697eaf060664b536cda00cecce78b9d5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_16469af1e3edfb0f655b4990317fb65b
bibliographicCitation	Zhu D, Jiang T, Ma D, Zhang H, Zhang J, Lv W, Gong M, Wang H, Liu Z, Su H, Zeng L, Liu S, Tang S, Yang B, Tshavuka FI, Fu G, Liu Z, Peng D, Liu H, Yan Z, Cao Z, Zhao H, He TC, Yu J, Shu Y, Zou L. S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist. Leukemia. 2023 Oct;37(10):1982–93. doi: 10.1038/s41375-023-02000-0. PMID: 37591940.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2192-2384 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9982-4805 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a51d94f2f224cba3ca5b68fb3b193f99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59f54160d5a8afd2210f515381cd7209 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52e6bda34a9372d961746f83d2ef6b45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9f8598991a752fb95cda9308933b6ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e12c0011931b111e4bfa5aefb1631b4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4854-1784 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e0fb5c2226fbd0065178ff070ac42fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59a17c3d67c5fc83c5193786d10fe743 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a9840a727604f963e192e6c0b3eff8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7061-3481 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fdb574eaf2b27a29a23fe8612418329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7df3e5f4c2e6d98211d517b53ffac1e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8caeaa44da2607e6412e3588500ec22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93c200ea6f1baeee0c90163c3c350f4b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_751329e10eb3affe518f073189a0465b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33944fee2bf8ab01a2e7f67d88482237 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5119dbb46d40c61249952d97f99cc44c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_350bf4eaf2bad31c2c8f2ccb638ac34a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2dc29df8a62ff64bc47069cb8b89c0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecbe2491448b14a82e645cb8a7fa8b3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c89c8bf0284dc3f28bf749d226d87aa4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9830273d08185f093a3fa18d584d80b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdf055e8296fe8056dad3df2e186d781 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f13d34cedc8e65f4f286821b6723377
date	2023-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41375-023-02000-0 https://pubmed.ncbi.nlm.nih.gov/37591940
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536 https://portal.issn.org/resource/ISSN/0887-6924 https://portal.issn.org/resource/ISSN/1476-5551
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist
discusses	http://id.nlm.nih.gov/mesh/M000625040 http://id.nlm.nih.gov/mesh/M0545566 http://id.nlm.nih.gov/mesh/M0184132 http://id.nlm.nih.gov/mesh/M0215816 http://id.nlm.nih.gov/mesh/M0481850
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_60a2bfa0ed69c09a2613bee76e2e6b99 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b0f6bb59123f97c7af890df63dc61e9a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6e48dbb6ed6753d9208ab5ddf3c20e97 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b34113852f5fdcfc4c30346793d002c2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16046248 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7cb1936ed09ffce83092f8d0384470cd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11044 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a03cbeca561fb1c14c97da4488860cbe http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1a9fd16e4a9ee3ac7708efecfbed0c0d

Total number of triples: 66.